top of page

Featured article on NoCamels

Aug 8, 2023

ExoProTher's groundbreaking approach to cancer treatment has gained well-deserved recognition with a featured article on NoCamels, a leading source of Israeli innovative technology and science news. Titled "Revolutionary Protein-Based Cancer Drug Targets Tumors Without Harming Healthy Cells," the article highlights ExoProTher's achievement in developing a protein-based cancer drug that demonstrates an exceptional ability to selectively target cancerous cells while sparing healthy ones.
The featured interview with Lana Volokh, CEO and Alex Tendler, CTO of ExoProTher’s presents our unique approach to cancer therapy.
The article further highlights ExoProTher's commitment to revolutionizing cancer therapy and impacting cancer patients' lives.

bottom of page